DocGo Analyst Price Targets - Benzinga

SPY752.88+0.10%QQQ682.55+0.21%BTC/USD76,769.83+0.12%DIA519.00−0.07%GLD362.74+0.30%TLT81.61−0.15%

Premium Services

Premium Services

DocGo Inc

DCGONASDAQ

Trade with Public

Trade with Public

$0.2140

-0.0329-13.33%

Last update: Nov 2, 7:51 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

© 2026 Benzinga | All Rights Reserved

DocGo Analyst Price Targets - Benzinga

DocGo Analyst Price Targets

Wall Street analyst price targets and consensus rating for DocGo (DCGO).

Price Target Range — 10 Quarters

Analyst Consensus — 5 Analysts

4Buy

1Hold

Consensus RatingBuy# Analysts5Avg. Consensus PT$3Upside to Avg. PT+1480.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 30, 2026	Needham	Ryan MacDonald	Maintained	Buy	$3
Aug 18, 2026	Canaccord Genuity	Richard Close	Maintained	Hold	$1
Aug 18, 2026	Needham	Ryan MacDonald	Maintained	Buy	$3
May 11, 2026	Cantor Fitzgerald	Sarah James	Suspends	Overweight	—
Mar 25, 2026	Canaccord Genuity	Richard Close	PT Cut	Hold	$2→$1
Mar 17, 2026	Stifel	David Grossman	PT Cut	Buy	$4→$3
Mar 17, 2026	Cantor Fitzgerald	Sarah James	Maintained	Overweight	$3
Mar 17, 2026	Needham	Ryan MacDonald	Maintained	Buy	$3
Nov 12, 2025	Canaccord Genuity	Richard Close	PT Cut	Hold	$2→$2
Aug 21, 2025	Canaccord Genuity	Richard Close	PT Raise	Hold	$1→$2
May 12, 2025	Canaccord Genuity	Richard Close	Downgrade	Buy→Hold	$5→$1
May 9, 2025	Needham	Ryan MacDonald	PT Cut	Buy	$4→$3
Apr 8, 2025	Needham	Ryan MacDonald	Maintained	Buy	$4
Feb 28, 2025	Stifel	David Grossman	PT Cut	Buy	$7→$6
Feb 28, 2025	Needham	Ryan MacDonald	PT Cut	Buy	$7→$4
Jan 16, 2025	Needham	Ryan MacDonald	Maintained	Buy	$7
Sep 20, 2024	Cantor Fitzgerald	Sarah James	Maintained	Overweight	$5
Aug 20, 2024	Cantor Fitzgerald	Sarah James	Maintained	Overweight	$5
Aug 8, 2024	Needham	Ryan MacDonald	Maintained	Buy	$7
May 9, 2024	BTIG	David Larsen	PT Cut	Buy	$11→$7

Analyst Ratings News

PRO
Needham Reiterates Buy on DocGo, Maintains $3 Price Target

Needham analyst Ryan MacDonald reiterates DocGo (NASDAQ:DCGO) with a Buy and maintains $3 price target.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on DocGo, Maintains $3 Price Target

Needham analyst Ryan MacDonald reiterates DocGo (NASDAQ:DCGO) with a Buy and maintains $3 price target.

Benzinga Newsdesk

DocGo Likely To Report Narrower Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

DocGo Inc. (DCGO) to report Q2 earnings on Aug. 17. Expected loss of 15 cents/share. Raised FY sales guidance. Analysts have mixed ratings.

Avi Kapoor

PRO
Cantor Fitzgerald Suspends Overweight Rating on DocGo

Cantor Fitzgerald suspends Overweight rating on DocGo (NASDAQ:DCGO).

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on DocGo, Lowers Price Target to $1

Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Hold and lowers the price target from $1.5 to $1.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on DocGo, Lowers Price Target to $2.5

Stifel analyst David Grossman maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $4 to $2.5.

Benzinga Newsdesk